Post-Traumatic Stress Disorder (PTSD) Research

The Mood and Anxiety Disorders Program (MAP) is researching a range of new treatments for post-traumatic stress disorder (PTSD). Our studies include research into finding novel uses for current medications such as ketamine (an FDA-approved anesthetic) and developing new drugs.

Clinical Trials for Post-Traumatic Stress Disorder (PTSD)

MAP is currently seeking individuals interested in participating in the following clinical trials for PTSD.

To participate in one of our clinical trials for Mood and Anxiety Disorders or to learn more about eligibility, please contact us (212-241-6539;


Contact Us

Tel: 212-241-6539
Fax: 212-241-3354
Send e-mail

Atran Berg Laboratory Building
Floor E Level
1428 Madison Avenue
New York, NY 10029  Map

Participate in PTSD Clinical Trials

If you are interested in participating, see our current list of clinical trials.